Arcadia Biosciences Inc (RKDA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) has a cash flow conversion efficiency ratio of -0.208x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-861.00K) by net assets ($4.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Arcadia Biosciences Inc (RKDA) net asset quality to measure how much of total assets are equity-financed.
Arcadia Biosciences Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Arcadia Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Arcadia Biosciences Inc (RKDA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Arcadia Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arcadia Biosciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oakridge International Ltd
AU:OAK
|
-0.447x |
|
Cho Thavee Public Company Limited
BK:CHO
|
-0.006x |
|
Reneuco Berhad
KLSE:7130
|
0.013x |
|
Vault Strategic Mining Corp.
V:KNOX
|
0.054x |
|
CardioComm Solutions Inc.
V:EKG
|
0.215x |
|
Erech Finance Cahalacha Ltd
TA:EFNC
|
-0.213x |
|
Ausmon Resources Ltd
AU:AOA
|
-0.232x |
|
Forward Water Technologies Corp
V:FWTC
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Arcadia Biosciences Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Arcadia Biosciences Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see RKDA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.14 Million | $-4.74 Million | -1.145x | +26.01% |
| 2024-12-31 | $6.22 Million | $-9.63 Million | -1.547x | -28.49% |
| 2023-12-31 | $12.70 Million | $-15.29 Million | -1.204x | -80.03% |
| 2022-12-31 | $20.90 Million | $-13.98 Million | -0.669x | +19.35% |
| 2021-12-31 | $31.20 Million | $-25.87 Million | -0.829x | +21.65% |
| 2020-12-31 | $28.55 Million | $-30.22 Million | -1.058x | +48.76% |
| 2019-12-31 | $8.33 Million | $-17.20 Million | -2.066x | -94.19% |
| 2018-12-31 | $12.81 Million | $-13.63 Million | -1.064x | +39.01% |
| 2017-12-31 | $8.01 Million | $-13.96 Million | -1.744x | -127.00% |
| 2016-12-31 | $22.20 Million | $-17.05 Million | -0.768x | -104.55% |
| 2015-12-31 | $40.23 Million | $-15.11 Million | -0.376x | -104.79% |
| 2014-12-31 | $-1.89 Million | $-14.79 Million | 7.845x | +1292.38% |
| 2013-12-31 | $-17.30 Million | $-9.74 Million | 0.563x | -66.60% |
| 2012-12-31 | $-5.68 Million | $-9.59 Million | 1.687x | -- |
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more